Related Experiment Video
Updated: Jun 14, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Increasing Prevalence of Cannabinoid Hyperemesis Syndrome in Young Adults and Minority Populations
Akari Miki1, Megha Tandon1, Dina Murad1,2
1Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
Introduction:
Prevalence rates for cannabinoid hyperemesis syndrome (CHS) across demographic groups remain unclear.
Methods:
We used data from the Massachusetts Center for Health Information and Analysis to estimate the rates of CHS from 2012 to 2021, across >15 million emergency department visits and demographic groups.
Results:
CHS cases per 10,000 emergency department visits increased from 0.729 to 10.6 in Massachusetts (2012-2021). Individuals aged 18-34 years experienced the fastest rise in CHS prevalence, with young adults, Hispanic individuals, Black individuals, and men having the overall highest 10-year prevalence.
Discussion:
Younger adults, Hispanic individuals, and Black individuals may be at higher risk for presenting with CHS.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Factors Affecting Drug Response: Overview
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

